Lupin Expands U.S. Portfolio With FDA-Approved Sugammadex
MUMBAI, India and NAPLES, Fla., July 31, 2026 Lupin Limited has received approval from the U.S. Food and Drug...
Lupin
Advertisement
Lupin Boosts U.S. Generics Business with FDA Approval
MUMBAI, India, and NAPLES, Fla., July 28, 2026 Lupin Limited has received U.S. Food and Drug Administration (FDA) approval...
Valion Bio, Sheba Advance Entolimod Cancer Trial
SAN ANTONIO, July 20, 2026 Valion Bio, Inc. has announced a significant clinical development milestone after Sheba Medical Center,...
Lupin Spins Out Oncology Pipeline to Kaveri Therapeutics
MUMBAI, India & NAPLES, Fla., July 21, 2026 Lupin Limited has announced the strategic spin-out of two promising clinical-stage...
Lupin Earns TIME Recognition for Global Sustainability Leadership
MUMBAI, India, July 6, 2026 Lupin Limited, one of the world’s leading pharmaceutical companies, has been recognized among TIME...
Advertisements
Lupin Receives U.S. FDA Tentative Approval for Enzalutamide Tablets
MUMBAI, India & NAPLES, Fla., June 26, 2026 Lupin Limited announced that it has received tentative approval from the...
Lupin Wins FDA Approval for Ranluspec Biosimilar Eye Drug
Mumbai, India and Naples, Florida, June 5, 2026 Global pharmaceutical company Lupin Limited has secured a major regulatory milestone...
Lupin and Natco Win U.S. FDA Approval for Eribulin Injection
MUMBAI, India & NAPLES, Florida, USA, June 3, 2026 Lupin Limited and its alliance partner Natco Pharma have announced...
Lupin Receives US FDA EIR for Ankleshwar Manufacturing Site
MUMBAI, India, May 28, 2026 Lupin Limited, one of the world’s leading pharmaceutical companies, has announced that it has...
Lupin Wins U.S. FDA Approval for Famotidine Injection
MUMBAI, India and NAPLES, Fla., May 13, 2026 Global pharmaceutical company Lupin Limited announced that it has received approval...
Advertisement
